Melanoma cell invasiveness is promoted at least in part by the epidermal growth factor-like repeats of tenascin-C

Journal of Investigative Dermatology

Volumn 133, Issue 1, 2013, Pages 210-220

  Grahovac, Jelena ^a   Becker, Dorothea ^a   Wells, Alan ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; MYOSIN LIGHT CHAIN 2; PEPTIDES AND PROTEINS; PROTEIN MYPT; RHO KINASE; TENASCIN; UNCLASSIFIED DRUG;

ARTICLE; ASSAY; CANCER INVASION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MATRIGEL INVASION ASSAY; MELANOMA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

EID: 84872197518     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2012.263     Document Type: Article

References (48)

1. Amano M, Fukata Y, Kaibuchi K (2000) Regulation and functions of Rhoassociated kinase. Exp Cell Res 261:44-511
2. Aukhil I, Joshi P, Yan Y et al. (1993) Cell- and heparin-binding domains of the hexabrachion arm identified by tenascin expression proteins. J Biol Chem 268:2542-533
3. Chung CY, Murphy-Ullrich JE, Erickson HP (1996) Mitogenesis, cell migration, and loss of focal adhesions induced by tenascin-C interacting with its cell surface receptor, annexin II. Mol Biol Cell 7:883-922
4. De Wever O, Nguyen QD, Van Hoorde L et al. (2004) Tenascin-C and SF// HGF produced by myofibroblasts in vitro provide convergent proinvasive signals to human colon cancer cells through RhoA and Rac. FASEB J 18:1016-88
5. DiMilla PA, Barbee K, Lauffenburger DA (1991) Mathematical model for the effects of adhesion and mechanics on cell migration speed. Biophys J 60:15-377
6. DiMilla PA, Stone JA, Quinn JA et al. (1993) Maximal migration of human smooth muscle cells on fibronectin and type IV collagen occurs at an intermediate attachment strength. J Cell Biol 122:729-377
7. Friedl P (2004) Prespecification and plasticity: Shifting mechanisms of cell migration. Curr Opin Cell Biol 16:14-233
8. Friedl P, Gilmour D (2009) Collective cell migration in morphogenesis, regeneration and cancer. Nat Rev Mol Cell Biol 10:445-577
9. Friedl P, Zanker KS, Brocker EB (1998) Cell migration strategies in 3-D extracellular matrix: Differences in morphology, cell matrix interactions, and integrin function. Microsc Res Tech 43:369-788
10. Fukunaga-Kalabis M, Martinez G, Nguyen TK et al. (2010) Tenascin-C promotes melanoma progression by maintaining the ABCB5-positive side population. Oncogene 29:6115-244
11. Gaggioli C, Sahai E (2007) Melanoma invasion - current knowledge and future directions. Pigment Cell Res 20:161-722
12. Hanamura N, Yoshida T, Matsumoto E et al. (1997) Expression of fibronectin and tenascin-C mRNA by myofibroblasts, vascular cells and epithelial cells in human colon adenomas and carcinomas. Int J Cancer 73:10-55
13. Herlyn M, Graeven U, Speicher D et al. (1991) Characterization of tenascin secreted by human melanoma cells. Cancer Res 51:4853-88
14. Hood BL, Grahovac J, Flint MS et al. (2010) Proteomic analysis of laser microdissected melanoma cells from skin organ cultures. J Proteome Res 9:3656-633
15. Huang W, Chiquet-Ehrismann R, Moyano JV et al. (2001) Interference of tenascin-C with syndecan-4 binding to fibronectin blocks cell adhesion and stimulates tumor cell proliferation. Cancer Res 61:8586-944
16. Ilmonen S, Jahkola T, Turunen JP et al. (2004) Tenascin-C in primary malignant melanoma of the skin. Histopathology 45:405-111
17. Imai K, Kusakabe M, Sakakura T et al. (1994) Susceptibility of tenascin to degradation by matrix metalloproteinases and serine proteinases. FEBS Lett 352:216-88
18. Iyer AK, Tran KT, Borysenko CW et al. (2007) Tenascin cytotactin epidermal growth factor-like repeat binds epidermal growth factor receptor with low affinity. J Cell Physiol 211:748-588
19. Iyer AK, Tran KT, Griffith L et al. (2008) Cell surface restriction of EGFR by a tenascin cytotactin-encoded EGF-like repeat is preferential for motilityrelated signaling. J Cell Physiol 214:504-122
20. Jones PL, Jones FS (2000) Tenascin-C in development and disease: Gene regulation and cell function. Matrix Biol 19:581-966
21. Kaariainen E, Nummela P, Soikkeli J et al. (2006) Switch to an invasive growth phase in melanoma is associated with tenascin-C, fibronectin, and procollagen- I forming specific channel structures for invasion. J Pathol 210:181-911
22. Kassis J, Lauffenburger DA, Turner T et al. (2001) Tumor invasion as dysregulated cell motility. Semin Cancer Biol 11:105-177
23. Lammermann T, Sixt M (2009) Mechanical modes of ''amoeboid'' cell migration. Curr Opin Cell Biol 21:636-444
24. Lauffenburger DA, Horwitz AF (1996) Cell migration: A physically integrated molecular process. Cell 84:359-699
25. Midwood KS, Hussenet T, Langlois B et al. (2011) Advances in tenascin-C biology. Cell Mol Life Sci 68:3175-999
26. Nishio T, Kawaguchi S, Yamamoto M et al. (2005) Tenascin-C regulates proliferation and migration of cultured astrocytes in a scratch wound assay. Neuroscience 132:87-1022
27. Orend G (2005) Potential oncogenic action of tenascin-C in tumorigenesis. Int J Biochem Cell Biol 37:1066-833
28. Orend G, Chiquet-Ehrismann R (2000) Adhesion modulation by antiadhesive molecules of the extracellular matrix. Exp Cell Res 261:104-100
29. Orend G, Chiquet-Ehrismann R (2006) Tenascin-C induced signaling in cancer. Cancer Lett 244:143-633
30. Oskarsson T, Acharyya S, Zhang XH et al. (2011) Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs. Nat Med 17:867-744
31. Paron I, Berchtold S, Voros J et al. (2011) Tenascin-C enhances pancreatic cancer cell growth and motility and affects cell adhesion through activation of the integrin pathway. PLoS One 6:e216844
32. Ramos DM, Chen B, Regezi J et al. (1998) Tenascin-C matrix assembly in oral squamous cell carcinoma. Int J Cancer 75:680-77
33. Ren XD, Wang R, Li Q et al. (2004) Disruption of Rho signal transduction upon cell detachment. J Cell Sci 117(Pt 16):3511-88
34. Sahai E, Marshall CJ (2003) Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis. Nat Cell Biol 5:711-99
35. Sanz-Moreno V, Gaggioli C, Yeo M et al. (2011) ROCK and JAK1 signaling cooperate to control actomyosin contractility in tumor cells and stroma. Cancer Cell 20:229-455
36. Sanz-Moreno V, Marshall CJ (2009) Rho-GTPase signaling drives melanoma cell plasticity. Cell Cycle 8:1484-77
37. Sanz-Moreno V, Marshall CJ (2010) The plasticity of cytoskeletal dynamics underlying neoplastic cell migration. Curr Opin Cell Biol 22: 690-66
38. Siri A, Knauper V, Veirana N et al. (1995) Different susceptibility of small and large human tenascin-C isoforms to degradation by matrix metalloproteinases. J Biol Chem 270:8650-44
39. Soderberg O, Gullberg M, Jarvius M et al. (2006) Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat Methods 3:995-10000
40. Sriramarao P, Mendler M, Bourdon MA (1993) Endothelial cell attachment and spreading on human tenascin is mediated by alpha 2 beta 1 and alpha v beta 3 integrins. J Cell Sci 105(Pt 4):1001-122
41. Swindle CS, Tran KT, Johnson TD et al. (2001) Epidermal growth factor (EGF)- like repeats of human tenascin-C as ligands for EGF receptor. J Cell Biol 154:459-688
42. Tuominen H, Kallioinen M (1994) Increased tenascin expression in melanocytic tumors. J Cutan Pathol 21:424-99
43. Wallner K, Li C, Shah PK et al. (2004) EGF-Like domain of tenascin-C is proapoptotic for cultured smooth muscle cells. Arterioscler Thromb Vasc Biol 24:1416-211
44. Wells A (2000) Tumor invasion: Role of growth factor-induced cell motility. Adv Cancer Res 78:31-1011
45. Wenk MB, Midwood KS, Schwarzbauer JE (2000) Tenascin-C suppresses Rho activation. J Cell Biol 150:913-200
46. Wolf K, Mazo I, Leung H et al. (2003) Compensation mechanism in tumor cell migration: Mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J Cell Biol 160:267-777
47. Yoshida T, Matsumoto E, Hanamura N et al. (1997) Co-expression of tenascin and fibronectin in epithelial and stromal cells of benign lesions and ductal carcinomas in the human breast. J Pathol 182:421-88
48. Zaman MH, Trapani LM, Sieminski AL et al. (2006) Migration of tumor cells in 3D matrices is governed by matrix stiffness along with cell-matrix adhesion and proteolysis. Proc Natl Acad Sci USA 103: 10889-944